These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24028192)

  • 21. Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment.
    Galldiks N; Burghaus L; Dohmen C; Teschner S; Pollok M; Leebmann J; Frischmuth N; Hollinger P; Nazli N; Fassbender C; Klingel R; Benzing T; Fink GR; Haupt WF
    Eur Neurol; 2011; 66(4):183-9. PubMed ID: 21912134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.
    Härtig F; Ross M; Dammeier NM; Fedtke N; Heiling B; Axer H; Décard BF; Auffenberg E; Koch M; Rattay TW; Krumbholz M; Bornemann A; Lerche H; Winter N; Grimm A
    Neurotherapeutics; 2018 Apr; 15(2):439-451. PubMed ID: 29435815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
    Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Lewis RA; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van den Berg LH; van Doorn PA; Cornblath DR; Faber CG; Merkies IS;
    J Peripher Nerv Syst; 2015 Sep; 20(3):277-88. PubMed ID: 26110493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical-neurophysiological correlations in chronic inflammatory demyelinating polyradiculoneuropathy patients treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Ricciardi D; Tedeschi G
    Muscle Nerve; 2019 Dec; 60(6):662-667. PubMed ID: 31415091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INCAT disability score: a critical analysis of its measurement properties.
    Breiner A; Barnett C; Bril V
    Muscle Nerve; 2014 Aug; 50(2):164-9. PubMed ID: 24723454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional health status of patients with chronic inflammatory neuropathies.
    Erdmann PG; van Meeteren NL; Kalmijn S; Wokke JH; Helders PJ; van den Berg LH
    J Peripher Nerv Syst; 2005 Jun; 10(2):181-9. PubMed ID: 15958129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages.
    Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K
    Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy.
    Wilson JR; Park Y; Fisher MA
    Electromyogr Clin Neurophysiol; 2000; 40(3):181-5. PubMed ID: 10812541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Peric M; Arsic Azanjac A; Palibrk A; Bulatovic I; Aleksic D; Peric S; Basta I
    Qual Life Res; 2021 Sep; 30(9):2573-2579. PubMed ID: 33830457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A distinct subgroup of chronic inflammatory demyelinating polyneuropathy with CNS demyelination and a favorable response to immunotherapy.
    Pineda AA; Ogata K; Osoegawa M; Murai H; Shigeto H; Yoshiura T; Tobimatsu S; Kira J
    J Neurol Sci; 2007 Apr; 255(1-2):1-6. PubMed ID: 17306302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids.
    Muley SA; Kelkar P; Parry GJ
    Arch Neurol; 2008 Nov; 65(11):1460-4. PubMed ID: 19001164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early predictive factors of disability in CIDP.
    Spina E; Topa A; Iodice R; Tozza S; Ruggiero L; Dubbioso R; Esposito M; Bruzzese D; Santoro L; Manganelli F
    J Neurol; 2017 Sep; 264(9):1939-1944. PubMed ID: 28770373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
    Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathy.
    Bozovic I; Peric S; Basta I; Rakocevic-Stojanovic V; Lavrnic D; Stevic Z; Radovanovic S
    J Clin Neurosci; 2020 Oct; 80():6-10. PubMed ID: 33099368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy.
    Harbo T; Andersen H; Overgaard K; Jakobsen J
    J Peripher Nerv Syst; 2008 Sep; 13(3):208-17. PubMed ID: 18844787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
    Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
    Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity.
    Di Pasquale A; Morino S; Loreti S; Bucci E; Vanacore N; Antonini G
    Neurology; 2015 Feb; 84(8):803-9. PubMed ID: 25632087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.